About EMPE Diagnostics
EMPE Diagnostics is a company based in Solna (Sweden) founded in 2015 by Pavan Asalapuram. EMPE Diagnostics has raised $1.15 million across 5 funding rounds from investors including European Union, EIC Fund and Almi Invest. The company has 27 employees as of April 05, 2024. EMPE Diagnostics operates in a competitive market with competitors including OpGen, QuantuMDx, Oxford Immunotec, Avails Medical and Resistell, among others.
- Headquarter Solna, Sweden
- Employees 27 as on 05 Apr, 2024
- Founders Pavan Asalapuram
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Empe Diagnostics Private Limited
- Date of Incorporation 30 Oct, 2019
- Jurisdiction Hyderabad, Telangana, India
-
Annual Revenue
$693.33 K (USD)37.43as on Mar 31, 2023
-
Net Profit
$69.62 K (USD)645.87as on Mar 31, 2023
-
EBITDA
$125.41 K (USD)141.41as on Mar 31, 2023
-
Total Equity Funding
$1.15 M (USD)
in 5 rounds
-
Latest Funding Round
$52.86 K (USD), Grant
Feb 28, 2023
-
Investors
European Union
& 2 more
-
Employee Count
27
as on Apr 05, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of EMPE Diagnostics
Unlock access to complete
Unlock access to complete
Funding Insights of EMPE Diagnostics
EMPE Diagnostics has successfully raised a total of $1.15M across 5 strategic funding rounds. The most recent funding activity was a Grant round of $52.86 thousand completed in February 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in EMPE Diagnostics
EMPE Diagnostics has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, EIC Fund and Almi Invest.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked | |
|
Multiple sectors are invested in by corporate-backed Almi Invest.
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for EMPE Diagnostics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by EMPE Diagnostics
Investment portfolio details for EMPE Diagnostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - EMPE Diagnostics
Detailed financials for EMPE Diagnostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Empe Diagnostics Comparisons
Peer comparison for EMPE Diagnostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of EMPE Diagnostics
EMPE Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as OpGen, QuantuMDx, Oxford Immunotec, Avails Medical and Resistell, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of diagnostics and bioinformatics platforms for providers
|
|
| Locked | Locked | Locked |
Handheld diagnostic and sequencing devices are developed for personalized healthcare.
|
|
| Locked | Locked | Locked |
Immune markers are utilized by Oxford Immunotec for disease diagnostics.
|
|
| Locked | Locked | Locked |
Point-of-care devices are developed for infection diagnosis and treatment optimization.
|
|
| Locked | Locked | Locked |
Antibiotic susceptibility testing is provided via bacterial movement detection.
|
|
| Locked | Locked | Locked |
Develops rapid assay medical tests that use a single drop of blood to test for a variety of common conditions, illnesses and diseases
|
Detailed competitors of EMPE Diagnostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Empe Diagnostics
Complete news archive for EMPE Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about EMPE Diagnostics
EMPE Diagnostics was founded in 2015 and raised its 1st funding round 3 years after it was founded.
EMPE Diagnostics is headquartered in Solna, Sweden.
Pavan Asalapuram is the current CEO of EMPE Diagnostics. They have also founded this company.
EMPE Diagnostics is a funded company, having raised a total of $1.15M across 5 funding rounds to date.
As of Apr 05, 2024, the latest employee count at EMPE Diagnostics is 27.
Annual revenue of EMPE Diagnostics is $693.33K as on Mar 31, 2023.
EMPE Diagnostics was founded in 2015 in Solna, Sweden, within the medical diagnostics sector. Focus is placed on early-stage, point-of-care confirmatory tests for infectious diseases, particularly antimicrobial resistance in tuberculosis. The miniMDR-TB product identifies key mutations like rpoB 531 and katG 315 via visual signals on lateral flow strips in under 60 minutes. The miniXDR-TB test extends detection to multiple genetic markers in microscopy-positive samples during the same timeframe.
EMPE Diagnostics's top competitors include QuantuMDx, Avails Medical and OpGen.
EMPE Diagnostics has 3 investors. Key investors include European Union, EIC Fund, and Almi Invest.